morphine-3-glucosiduronate, morphine-6-glucosiduronate, morphine-3,6-diglucosiduronate, morphine-3-O-sulphate, morphine-6-O-sulphate, morphine-3,6-O-disulphate Biotransformation of heroin, codeine[edit | edit source] heroin can transform into morphine codeine can transform into morphine or codeine-6-glucosiduonate morphine then can undergo further biotransformation Biotransformation of cocaine[edit | edit source] cocaine is transformed into cocaethylene, norcocaine, benzoylecgonine, methylester ecgonine benzoylecgonine and methyl ester ecgonine can then further biotransform into ecgonine Biotransformation of methamphetamine[edit | edit source] Biotransformation of benzodiazepines[edit | edit source] Biotransformation of delta-9-THC[edit | edit source] THC (picture) 11-hydroxy-THC 9-carboxy-THC 9-carboxy-THC-mono/diglucosiduronate Kinetic aspects of biotransformation[edit | edit source] Knowledge of biotransformation[edit | edit source] development and optimization of the toxicological method interpretation of toxicological findings knowledge of the mechanism of action of xenobiotics for effective treatment of diseases and intoxications, reduction of adverse drug effects pharmacokinetics and pharmacodynamics: individual differences (genetic basis, health status, age, gender) effects are affected by dose, frequency of doses, method of application, combination of NOx (inhibition or induction of enzymes) etc

Stacking BPC-157 with other peptides, most commonly TB-500 (thymosin beta-4), has become prevalent in sports medicine circles
identified c-Met as a prometastatic gene and miR-146a as a negative regulator of c-Met in highly metastatic variants derived from MC38 cells
Management of acute cholangitis and the impact of endoscopic sphincterotomy
Greater loss of 5-HT2A receptors in midlife than in late life